Page 114 - 18F-FDG PET as biomarker in aggressive lymphoma; technical and clinical validation
P. 114
Chapter 5
Fig. 2. Scatterplot of final MTV assessment in Workflow C.
Fig. 3. Scatterplot of MTV assessment in Workflow C (automated preselection before (C1) – and final MTV after manual modification (C2), in milliliters).
Datapoints from two challenging patients (patients 10 and 11) are indicated by lines. The numbers in the boxes refer to the patient numbers described in the main text.
112
